|

Depletion of CD3/CD19 in an autologous stem cell transplant Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CD3/CD19 depletion using cliniMACs device

Pipeline

Phase 2: 1

Top Sponsors

  • Stephan Grupp MD PhD1

Indications

  • Systemic Sclerosis1
  • Systemic Lupus Erythematosus1
  • Lupus1

Philadelphia, Pennsylvania1 trial

Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

Children's Hospital of Philadelphia

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.